Herein, genetic inhibition of Ca2+ influx channel TRPM7 and OGA, which act upstream of ITGA4 and ITGB7, effectively inhibited experimental MM dissemination in vivo, suggesting the potential clinical applications of Ca2+ influx and O-GlcNAcylation modulators. This evidence concerns the gene OGA and Miyoshi myopathy.